Department of Neurology, University of Massachusetts, Worcester, MA, USA.
Department of Neurology, Brown University, Providence, RI, USA.
J Stroke Cerebrovasc Dis. 2022 Dec;31(12):106865. doi: 10.1016/j.jstrokecerebrovasdis.2022.106865. Epub 2022 Nov 1.
There is a relative paucity of data regarding long-term outcomes and treatment-related complications in women of childbearing age with cerebral venous sinus thrombosis (CVST). We sought to determine whether outcomes differ in women of childbearing age with versus without postpartum CVST.
We retrospectively analysed 373 non-pregnant females of childbearing age (18-45 years) included in the multicenter observational Anticoagulation in the Treatment of Cerebral Venous Thrombosis study (ACTION-CVT). Comparisons were made between postpartum (first 12 weeks from delivery, n=38 [10.2%]) versus non-postpartum women (n=335 [89.8%]). The primary outcomes of interest were one-year risk of all-cause death, venous thromboembolism (VTE) recurrence, and major hemorrhage (i.e., new or worsening intracranial hemorrhage or major extracranial hemorrhage). Secondary outcomes were the discharge disposition and modified Rankin Scale (mRS) score at discharge and 90 days.
Postpartum status was associated with greater risk of seizures (42.1% versus 20.9%, p=0.003), venous infarction (47.4% versus 29.5%, p=0.025), intracranial hemorrhage (55.3% versus 36.1%, p=0.022), and requirement for neurosurgical treatment (13.2% versus 3.6%, p=0.021). There was no significant association with one year all cause death (N=373 HR=1.35, 95%-CI=0.15-11.87, p=0.784), VTE recurrence (N=373, HR=1.27, 95%-CI=0.45-3.59, p=0.648), major hemorrhage (N=373, HR=1.36, 95%-CI=0.46-4.0, p=0.581) as well as excellent (mRS[0-1]: OR=1.58, 95%-CI=0.4-7.1, p=0.554) and good (mRS[0-2]: OR=0.92, 95%-CI=0.2-4.27, p=0.918) 90-day mRS. Results were similar after adjustment for potential confounders.
Although CVST in the 12-week postpartum period was more frequently associated with early complications, 90-day functional disability and one-year outcomes were similar to women with CVST unrelated to pregnancy.
关于处于生育年龄的伴有脑静脉窦血栓形成(CVST)的女性的长期结局和治疗相关并发症的数据相对较少。我们旨在确定产后(分娩后 12 周内)与非产后 CVST 患者的结局是否存在差异。
我们回顾性分析了纳入多中心观察性抗凝治疗脑静脉血栓形成研究(ACTION-CVT)的 373 例非妊娠育龄女性(18-45 岁)。比较了产后(38 例[10.2%])与非产后女性(335 例[89.8%])。主要观察终点为:1 年全因死亡、静脉血栓栓塞(VTE)复发和主要出血(即新发或加重颅内出血或重大颅外出血)的风险。次要结局为出院时和 90 天时的出院安置和改良 Rankin 量表(mRS)评分。
产后状态与癫痫发作(42.1%比 20.9%,p=0.003)、静脉梗死(47.4%比 29.5%,p=0.025)、颅内出血(55.3%比 36.1%,p=0.022)和需要神经外科治疗(13.2%比 3.6%,p=0.021)的风险增加有关。与 1 年全因死亡率(N=373 HR=1.35,95%-CI=0.15-11.87,p=0.784)、VTE 复发(N=373 HR=1.27,95%-CI=0.45-3.59,p=0.648)、主要出血(N=373 HR=1.36,95%-CI=0.46-4.0,p=0.581)以及极好(mRS[0-1]:OR=1.58,95%-CI=0.4-7.1,p=0.554)和良好(mRS[0-2]:OR=0.92,95%-CI=0.2-4.27,p=0.918)90 天 mRS 评分均无显著相关性。在调整了潜在混杂因素后,结果相似。
尽管产后 12 周内的 CVST 更常伴有早期并发症,但 90 天的功能障碍和 1 年的结局与与妊娠无关的 CVST 患者相似。